Skip to main content
. Author manuscript; available in PMC: 2014 Oct 16.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Nov 22;85(5):1206–1211. doi: 10.1016/j.ijrobp.2012.10.008

Table 2. Pretreatment characteristics by 0211 and historical data set (7401, 7918, 8302, 9006, 9411).

There appear to be no differences in overall survival, neither in the group of all patients nor in patient groups stratified by.RPA class.

RTOG 0211 Historical control
n % n %
Age
 <50 30 22 487 33
 >= 50 106 78 970 67
Zubrod
 0 57 42 629 43
 1 79 58 684 47
 2,3 0 0 143 10
 unknown/missing 0 0 1 <1
Surgery
 biopsy 31 22 241 17
 part.resect 68 51 878 60
 tot.resect 36 26 328 23
 other 1 1 8 1
 unknown/missing 0 0 2 <1
Neurologic Function
 none/minor 107 79 794 54
 moderate 27 20 582 40
 hospital 0 0 77 5
 unknown/missing 2 1 4 <1
RPA Class
 III 12 9 250 17
 IV 83 61 652 45
 V 41 30 555 38
HHS Vulnerability Disclosure